지씨지놈

340450KOSDAQ

56.0 / 100

Reference Date: 2026-10-23

Financial Score16.5 / 40

News Sentiment12.5 / 25

Momentum17.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Surged 50.6% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

GC Genomics is a clinical genomics analysis company established in 2013, specializing in developing precision medicine technologies that utilize genomic big data for disease prevention and personalized treatment. Its core business includes four areas: prenatal/neonatal screening, cancer precision diagnosis, rare disease diagnosis, and health check-ups, with services provided to over 1,000 medical institutions domestically and 22 countries globally, solidifying its market position internationally.

Number of Employees

131people

Average Salary

53.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

54.22Industry Average 15.000.0Point

3.6x industry avg (risky)

PBR

3.03Industry Average 1.200.0Point

2.5x industry avg (risky)

ROE

7.26Industry Average 8.002.5Point

Below industry avg

Debt Ratio

4.62Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 6.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

3.0 / 4

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position8.0Point

Near 52w high (96%, uptrend)

Current 10,030Won52-week high 10,22052-week low 4,310

1-month return6.0Point

1m +50.60% (strong rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0